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Quantification of Ventricular Repolarization
Variation for Sudden Cardiac Death Risk
Stratification in Atrial Fibrillation
Alba Martı´n-Yebra, Pablo Laguna, Iwona Cygankiewicz, Antoni Baye´s-de-Luna, Enrico G. Caiani
and Juan Pablo Martı´nez
Abstract—Objective: Atrial fibrillation (AF) rhythm gives rise
to an irregular response in ventricular activity, preventing the
use of standard ECG-derived risk markers based on ventricular
repolarization heterogeneity under this particular condition. In
this study we proposed new indices to quantify repolarization
variations in AF patients, assessing their stratification perfor-
mance in a chronic heart failure (CHF) population with AF.
Methods: We developed a method based on a selective bin
averaging technique. Consecutive beats preceded by a similar RR
interval were selected, from which the average variation within
the ST-T complex for each RR range was computed. We proposed
two sets of indices: (i) the 2-beat index of ventricular repolariza-
tion variation, (IV2), computed from pairs of stable consecutive
beats; and (ii) the 3-beat indices of ventricular repolarization
variation, computed in triplets of stable consecutive beats (IV3).
Results: These indices showed a significant association with
sudden cardiac death (SCD) outcome in the study population.
In addition, risk assessment based on the combination of the
proposed indices improved stratification performance compared
to their individual potential. Conclusion: Patients with enhanced
ventricular repolarization variation computed in terms of the
proposed indices were successfully associated to a higher SCD
incidence in our study population, evidencing their prognostic
value. Significance: using a simple ambulatory ECG recording, it
is possible to stratify AF patients at risk of SCD, which may help
cardiologists in adopting most effective therapeutic strategies,
with a positive impact in both the patient and healthcare systems.
Index Terms—Electrocardiogram (ECG), ventricular repolar-
ization instability, atrial fibrillation (AF), sudden cardiac death
(SCD).
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ATRIAL FIBRILLATION (AF) is the most prevalentsustained arrhythmia and it has become one of the most
important public health issues in developed countries. It is
expected to double its incidence by 2030 [1, 2], representing
the major cause of hospitalizations in elderlies (≥65 years),
together with chronic heart failure (CHF). Indeed, AF and
CHF, which frequently occur together, are both leading causes
of morbidity and mortality worldwide, with an increasing
incidence and prevalence with age, having an adverse impact
in the quality of life of these patients [3].
It has been shown that most deaths occurring in AF patients,
even being properly anticoagulated, were actually not related
to stroke, thus raising the need for identifying other possible
actors and effective interventions to reduce mortality in AF
[4]. In fact, recent data have pointed out the independent
contribution of AF to sudden cardiac death (SCD) risk [5–8],
most of these deaths appearing as a consequence of malignant
ventricular arrhythmias. Current therapeutic alternatives in this
target population aim to restore and maintain sinus rhythm and
to keep the ventricular rate under control [3]. In particular,
implantable cardioverter-defibrillators (ICDs) can protect from
SCD by terminating ventricular tachyarrhythmias. However,
it is difficult to identify those patients who could potentially
benefit from this therapy, especially in the AF setting.
The predictive value of electrical instability assessed on
the electrocardiogram (ECG) signal has been widely stud-
ied. Specifically, enhanced ventricular repolarization hetero-
geneities, which can be quatified through the analysis of the
T-wave of the ECG, have been associated with SCD risk
and several non-invasive markers have been proposed [9–11].
However, the occurrece times of ventricular contractions dur-
ing AF are highly irregular and this singularity prevents from
the use of most of those indices, including QT-interval duration
and dispersion [12, 13], the Tpeak-to-Tend interval [14, 15],
T-wave alternans (TWA) [16], or the recently proposed T-wave
morphology restitution (TMR) [17], in the AF population, as
they require the patient to be in sinus rhythm to be properly
assessed.
From the hypothesis that a non-invasive stratification of AF
patients at risk of SCD is possible by assessing ventricular
repolarization in the electrocardiogram signal, the aim of this
study is to propose new measurements of ventricular repo-
larization beat-to-beat variations, suitable for ECG recordings
during AF, using a selective heart-rate bin averaging technique,
and to evaluate whether the proposed indices provide prognos-
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tic value for SCD in a CHF population with AF. A preliminary
version of this work has been reported in [18].
II. METHODS
A. Preprocessing
First, ventricular complexes were detected in each ECG
recording using the Aristotle software [19] and the RR series
along the whole recording were computed, defining the RR
interval associated to the ith beat as illustrated in Fig. 1.
Then, after baseline wander removal by high-pass linear
filtering, the ECG was low-pass filtered (cut-off frequency of
15 Hz) in order to cancel noise out of the T-wave frequency
band, and down-sampled by a factor of 2. Finally, the vector-
magnitude of the vectorcardiogram (VCG) signal was also
obtained using the three orthogonal leads (X,Y,Z).
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Fig. 1. Illustration of the vector-magnitude of an ECG signal with main
explicative intervals.
B. Selective beat averaging
We proposed the use of a concept similar to selective beat
averaging technique [20] to compute the average ventricular
repolarization variation in consecutive beats grouped by bins
of similar RR. The algorithm proceeds as follows:
1) After automatic identification, ventricular QRS − T
complexes were grouped based on their associated RR
interval. To do that, we first define the set S by all
triplets of consecutive beats within the Holter recording:
(i, i + 1, i + 2), for any initial beat i. We then sub-
divide the considered range of RRs (initially between
minRR = 300 ms and maxRR = 1600 ms) into K
bins, denoted as Ik, (k = 1, · · · ,K). For each bin,
an associated subset Sk is defined as containing those
triplets in S whose first element i is included in Ik, and
whose difference between consecutive RR intervals (i.e,
between RR(i+ 1) and RR(i), and between RR(i+ 2)
and RR(i+1)) is lower than half of the bin width. That
is:
Sk = {(i, i+ 1, i+ 2)} (1)
where
{
RR(i) ∈ Ik, |RR(i+ 1)−RR(i)| ≤ δ2 ,
|RR(i+ 2)−RR(i+ 1)| ≤ δ2
}
(2)
Ik =
{
RR(i) : minRR+ (k − 1)δ ≤ RR(i)
≤ minRR+ kδ} (3)
We set the bin width as δ=40 ms. In this step, basically
triplets of consecutive beats that were preceded by a
similar RR interval were selected, thus allowing the
assumption of stability.
2) For each triplet of beats included in Sk, two T-wave
variation waveforms, ∆T1(n) and ∆T2(n), were com-
puted as the difference between each pair of consecutive
ST-T complexes:
∆T(i,1)(n) = T(i+1)(n)− T(i)(n) (4)
∆T(i,2)(n) = T(i+2)(n)− T(i+1)(n), n = 1, . . . , N
(5)
where Ti(n) denotes the ST-T complex of the ith beat
(Fig. 1), set as a fixed window of 300 ms after QRS
complex end, with n the index of the sample within the
complex.
3) From ∆T1(n) and ∆T2(n) waveforms, two measure-
ments of ventricular variability were derived:
v+i (n) =
∆T(i,1)(n)+∆T(i,2)(n)
2 (6)
v−i (n) =
∆T(i,1)(n)−∆T(i,2)(n)
2 , (7)
where v+i (n) quantifies the average repolarization vari-
ation in each triplet, and v−i (n) measures the alternant
repolarization variation along the three consecutive sta-
ble beats. In the following, we will use vector notation,
being v+i and v
−
i the column vectors whose elements
are the samples of v+i (n) and v
−
i (n), respectively.
4) These repolarization variation waveforms are of low
amplitude, usually as low as a few microvolts, and there-
fore, we propose to apply signal averaging to enhance
and quantify them in a given bin Ik. Before averaging,
we need to aling all waveforms, similarly to what was
done in [21] for TWA analysis. In this case, the phase-
aligned waveforms, va+i and v
a−
i , were estimated as:
va+i = sign
(
v+Ti w
+
1
)
v+i (8)
va−i = sign
(
v−Ti w
−
1
)
v−i (9)
where w+1 is the first eigenvector associated to the
largest eigenvalue λ+1 of the correlation matrix Rv+
estimated from all variation vectors v+i , and w
−
1 is
the first eigenvector associated to the largest eigenvalue
λ−1 of the correlation matrix Rv− estimated from all
variation vectors v−i (a more detailed description can
be found in [21]).
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5) Finally, the average repolarization variation associated
to the kth bin, i.e. the subset Sk, denoted as v+k is
defined as the median waveform of all va+i computed
for the respective bin. The alternant variation waveform
associated to the same bin, denoted as v−k , is obtained
in an analogous way.
C. The 3-beat indices of ventricular repolarization variation
Based on these two measurements, we proposed two indices
to characterize the repolarization variation in the 24-hour
Holter recording: the index of average repolarization variation
and the index of alternant variation within sequences of 3
beats, I+V3 and I
−
V3, respectively. They were calculated as the
mean absolute value of the average waveform of all bins (of
all va+k and v
a−
k , respectively). That is:
I+V3 =
1
N
N∑
n=1
∣∣∣∣∣ 1K
K∑
k=1
va+k (n)
∣∣∣∣∣ (10)
I−V3 =
1
N
N∑
n=1
∣∣∣∣∣ 1K
K∑
k=1
va−k (n)
∣∣∣∣∣ (11)
with N the number of samples in the ST-T complex.
Both indices were also computed on each individual lead,
denoted as I+V3X, I
+
V3Y, I
+
V3Z, I
−
V3X, I
−
V3Y and I
−
V3Z for leads X ,
Y and Z, respectively. Additionally, we defined the heart-
rate restricted indices, I+90V3 and I
−90
V3 , by including only
bins associated to heart rates faster than 90 beats/min (i.e.
RR <660 ms).
D. The 2-beat index of ventricular repolarization variation
Instantaneous beat-to-beat repolarization variation in 2-beat
sequences, denoted as IV2, was also computed, following a
similar approach, but considering only pairs of 2 consecutive
beats (i, i+ 1) with similar RR. Each subset S′k was defined
as:
S′k =
{
(i, i+ 1)
}
(12)
where
{
RR(i) ∈ Ik, |RR(i+ 1)−RR(i)| ≤ δ2
}
(13)
In this case, a single T-wave variation waveform was com-
puted for each pair of beats in S′k as ∆Ti(n) = T(i+1)(n) −
T(i)(n). Finally, the IV2 was defined as:
IV2 =
1
N
N∑
n=1
∣∣∣∣∣ 1K
K∑
k=1
∆T
a
k (n)
∣∣∣∣∣ (14)
where ∆T
a
k (n), analogous to the computation of the previous
indices, is the median variation waveform of all ∆Ti (n)
included in the corresponding subset S′k, after being aligned
in sign.
Also in this case, the index I90V2 , including bins associated
to heart rates faster than 90 beats/min, was computed.
E. Statistical analysis
Data are presented as median (25th; 75th percentiles) for
continuous variables and as number (percentage) for categor-
ical variables, unless otherwise specified.
We used the bidirectional Mann-Whitney and Fisher exact
tests to evaluate differences between SCD and non-SCD
groups in quantitative and categorical data, respectively. Sur-
vival probability was estimated by the Kaplan-Meier method
and the association between groups and SCD outcome by
the log-rank test. Finally, univariate Cox proportional hazard
analyses were performed in order to evaluate the potential
prognostic value of the proposed indices for SCD stratification.
Our study population is reduced in terms of SCD events
(n=19) and this limited the construction of a multivariate
model with more than two covariates (at least 10 events
are required for each covariate included in the model [22]).
After univariate analysis, bivariate Cox proportional models
combining the indices with other clinical and pharmacological
variables that resulted associated to SCD in univariate analysis
were constructed. For all tests, a p-value≤0.05 was considered
as statistically significant.
III. DATA SET
The prognostic value of the indices has been assessed by
analyzing ambulatory ECG recordings (24-h Holter) from CHF
patients with permanent AF. Patients were recruited in the
multicenter, prospective MUSIC (MUerte Su´bita en Insuficien-
cia Cardiaca) study, which aimed at assessing risk predictors
for cardiac mortality in heart failure [23]. The recruitment
took place between April 2003 and December 2004 at eight
Spanish university hospitals. The initial cohort included 992
consecutive patients with symptomatic CHF, belonging to
functional classes II and III according to the New York Heart
Association (NYHA) classification, with both preserved and
reduced left ventricular ejection fraction (LVEF). Data for
demographic and clinical characteristics and medication were
collected at enrolment. For each subject, a 24-hour Holter ECG
recording containing three (95.3%) or two orthogonal leads
(X, Y, Z) sampled at 200 Hz were acquired with SpiderView
recorders (ELA Medical, Sorin Group, Paris, France).
From the original cohort, the 171 patients (128 males,
68.9±10.4 years) with permanent AF were selected for this
study. In this AF subgroup, the 71.3% of patients were in
NYHA class II, with average LVEF of 39.4±15.7%, half of
them (50.9%) with reduced LVEF (≤35%). Ischemic etiology
of CHF was present in 26.9% of patients. Finally, intraven-
tricular conduction delay (QRS duration >0.12 s) was present
in 71 patients. The main patient characteristics of the study
group are summarized on Table I.
Follow-up period was conducted for an average of 48
months, including periodic visits every 6 months. At the
end of the follow-up period, the study group included 19
events of SCD, 24 deaths due to a different cardiac origin,
20 non-cardiac deaths and 108 survivors. SCD was defined
by the study’s End-point Committee. The study protocol was
approved by the institutional ethical boards and all patients
sing informed consent [23].
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Fig. 2. Distribution of IV3 and IV2 indices for non-SCD and SCD groups. *: p≤0.05 non-SCD vs SCD.
TABLE I
CLINICAL CHARACTERISTICS OF THE STUDY POPULATION. DATA ARE
EXPRESSED AS MEAN±STANDARD DEVIATION AND AS ABSOLUTE
FREQUENCIES (PERCENTAGE).
Overall population SCD group Non-SCD group
(n=171) (n=19) (n=152)
Age (years) 68.9±10.4 69.2±10.5 68.9±10.4
Gender (males) 128 (74.8%) 16 (84.2%) 112 (73.7%)
LVEF ≤ 35% 87 (50.9%) 14 (73.7%) 73* (48.0%)
NYHA class III 49 (28.6%) 5 (26.3%) 44 (28.9%)
Diabetes 50 (29.2%) 6 (31.6%) 44 (28.9%)
Ischemic etiology 46 (26.9%) 10 (52.6%) 36* (23.7%)
Beta-blockers 100 (58.5%) 9 (47.3%) 91 (59.9%)
Amiodarone 25 (14.6%) 2 (10.5%) 23 (15.1%)
Digoxin 106 (62.0%) 11 (57.9%) 95 (62.5%)
QRSd ≥ 120 ms 71 (41.5%) 11 (57.9%) 60 (39.5%)
*p≤0.05 SCD vs Non-SCD groups
SCD: Sudden cardiac death
LVEF: Left ventricular ejection fraction
NYHA: New York Heart Association; QRSd: QRS duration.
IV. RESULTS
Distributions of I+V3, I
−
V3, I
+90
V3 and I
−90
V3 are presented in
Fig. 2, for both SCD and non-SCD groups of patients. SCD
outcome was associated in most cases with higher values, that
is, with higher repolarization variability. I+V3 and I
−
V3 were not
computable in 8 out of 171 Holter recordings (4.7%) as only
2 leads were available and the vector-magnitude of the VCG
could not be computed. Moreover, the additional restriction
imposed when computing I+90V3 and I
−90
V3 , by considering
only bins of RRs associated to HR≥90 beats/min, led to
the exclusion of 7 additional recordings (8.7% of the total
population) in which there was not any suitable triplet of
beats accomplishing the conditions in that range. Additionally,
distributions of IV2 and I90V2 values for both groups are also
presented in Fig. 2. While IV2 values did not present significant
differences between SCD and non-SCD groups, I90V2 was higher
in SCD group in comparison with the non-SCD group, though
not statistically significant (21.21 (13.7;69.93) µV vs 17.1
(11.49;26.296) µV, NS). In this case, I90V2 was not computable
in 10 out of 171 recordings, either because the recording had
only 2 leads (8 recordings) or because no pair of beats was
found suitable for the analysis (2 recordings).
The individual predictive value of each index was tested.
To do that, patients were classified by setting a risk threshold
thrisk corresponding to the third quartile (Q3) of the total
distribution of IV3 values (i.e. as IV3(+) if IV3 ≥ thrisk
and as IV3(−), otherwise). Thus, for each index, the positive
(+) group will contain the 25% of patients with the highest
values. Univariate analysis demonstrated that I+V3X, I
+90
V3X , I
−90
V3 ,
I+V3X and I
−90
V3X were successfully associated to SCD outcome
(see Table II). Also in this case, patients were classified as
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TABLE II
ASSOCIATION OF IV3 AND I90V2 INDICES WITH MORTALITY IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION.
SCD PFD non-CD Total mortality
HaR p-value HaR p-value HaR p-value HaR p-value
(95% CI) (95% CI) (95% CI) (95% CI)
I+V3 ≥ 22.650 µV
2.45 0.054 1.97 0.126 0.40 0.224 1.46 0.177
(0.98,6.08) (0.83,4.69) (0.09,1.75) (0.84,2.54)
I+90V3 ≥32.517 µV
2.15 0.113 1.98 0.123 0.23 0.156 1.38 0.281
(0.83,5.55) (0.83,4.73) (0.03,1.75) (0.77,2.46)
I+V3X ≥11.752 µV
2.97 0.018 1.12 0.816 1.12 0.832 1.55 0.106
(1.21,7.31) (0.44,2.81) (0.41,3.07) (0.91,2.64)
I+90V3X ≥17.332 µV
2.97 0.022 2.27 0.051 1.18 0.772 2.09 0.007
(1.17,7.53) (0.99,5.21) (0.38,3.63) (1.23,3.56)
I−V3 ≥ 28.101 µV
2.38 0.062 1.58 0.319 0.39 0.203 1.31 0.341
(0.96,5.93) (0.64,3.87) (0.09,1.68) (0.75,2.30)
I−90V3 ≥ 56.334 µV
2.91 0.024 2.15 0.084 0.54 0.414 1.77 0.047
(1.15,7.39) (0.90,5.13) (0.12,3.38) (1.01,3.09)
I−V3X ≥ 20.287 µV
2.88 0.021 1.34 0.519 0.36 0.173 1.29 0.356
(1.17,7.08) (0.55,3.22) (0.08,1.56) (0.75,2.24)
I−90V3X ≥ 34.133 µV
3.76 0.005 2.72 0.016 0.53 0.396 2.12 0.006
(1.49,9.48) (1.21,6.14) (0.12,2.31) (1.24,3.62)
I90V2 ≥ 28.86 µV
2.66 0.035 2.58 0.028 0.45 0.280 1.73 0.049
(1.07,6.63) (1.10,6.06) (0.10,1.93) (1.00,2.98)
SCD: Sudden cardiac death; PFD: Pump failure death; non-CD: non-cardiac death; HaR: Hazard ratio.
I90V2 (+) and I
90
V2 (−) by setting thrisk=28.86 µV, according to
the total distribution of I90V2 values. I
90
V2 (+) classified patients
were successfully associated with SCD outcome, with 2.66
increased risk compared to the negative group (see Table II).
However, the index lost its predictive value if no restriction in
HR was imposed (IV2).
In order to test whether repolarization variations measured
by the proposed indices are specifically associated with ar-
rhythmia propensity, we have also computed the prognostic
values of the proposed indices for other types of death of our
cohort: cardiac death due to pump failure (PFD) and non-
cardiac death (non-CD), as well as for total mortality. We
found that the only two indices associated with PFD were I−90V3X
and I90V2 , with lower hazard ratios than when associated to SCD,
while none of them were associated with non-cardiac death.
When considering total mortality, I+90V3X and I
−90
V3 , in addition
to I−90V3X and I
90
V2 , resulted associated with death outcome but
the obtained hazard ratios were lower than those obtained for
SCD prediction. Note that total mortality outcome includes
SCD as well as the other death types.
The Kaplan-Meier analysis for most significative indices
is shown on Fig. 3. Clearly, mortality rates were always
significantly higher in the positive (+) group in comparison to
patients classified as negative (−) at the end of the follow-up
period.
A. Combination of IV3 and IV2
An additional analysis was performed to assess whether the
use of combined indices would improve SCD risk stratifica-
tion. First, results derived from the analysis of I−V3 and I
+
V3
were combined, then additional information from I90V2 analysis
was also included. Results from univariate model are shown
in Table III. The combination of I−V3 and I
+
V3 improves the
single stratification performance of I−V3 and I
+
V3 in most of
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Fig. 3. Cumulative Kaplan-Meier probability curves for SCD associated to (a)
I−90V3X (b) I
+90
V3X , (c) I
90
V2 and (d) combination of I
+90
V3 & I
−90
V3 & I
90
V2 indices.
the cases. Nonetheless, better prognostic values are obtained
when I90V2 is also considered: the combination of patients that
were simultaneously classified as I−V3(+), I
+
V3(+) and I
90
V2 (+)
in the individual analysis, identified patients with more than
4-fold increased risk of SCD in the univariate analysis. The
best performance is obtained by considering patients at risk
according to I−V3X(+) and I
+
V3X(+) and I
90
V2 (+) (i.e, the group of
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patients that were classified as positive in these three cases:
I−V3X(+) & I
+
V3X(+) & I
90
V2 (+) group) which presented more than
6-fold increased risk of SCD. Kaplan-Meier survival curve is
shown in Fig. 3 (d).
TABLE III
ASSOCIATION OF THE COMBINATION OF IV3 AND I90V2 INDICES WITH
SUDDEN CARDIAC DEATH IN PATIENTS WITH HEART FAILURE AND ATRIAL
FIBRILLATION.
positive Univariate
patients HaR p-value
(%) (95% CI)
C1 = I+V3(+)&I
−
V3(+)
37 2.72 0.031
(21.6%) (1.09,6.77)
C2 = I+90V3 (+)&I
−90
V3 (+)
36 2.49 0.06
(21.1%) (0.96,6.42)
C3 = I+V3X(+)&I
−
V3X(+)
32 3.59 0.006
(18.7%) (1.44,8.94)
C4 = I+90V3X (+)&I
−90
V3X (+)
32 3.22 0.016
(18.7%) (1.25,8.33)
C5 = I+V3(+)&I
−
V3(+)&I
90
V2 (+)
19 4.29 0.003
(11.1%) (1.63,11.30)
C6 = I+90V3 (+)&I
−90
V3 (+)&I
90
V2 (+)
22 4.22 0.004
(12.9%) (1.58,11.30)
C7 = I+V3X(+)&I
−
V3X(+)&I
90
V2 (+)
15 6.49
<0.001
(8.8%) (2.46,17.14)
C8 = I+90V3X (+)&I
−90
V3X (+)&I
90
V2 (+)
15 4.47 0.005
(8.8%) (1.59,12.61)
LVEF: Left ventricular ejection fraction; HaR: Hazard ratio.
B. Bivariate model including clinical information
The prognostic value of significant clinical and pharma-
cological variables, including age, gender, NYHA class III,
LVEF≤35%, diabetes and antiarrhythmic drugs intake (beta-
blockers, digoxin and amiodarone) was also individually eval-
uated. Only LVEF≤35% was associated to SCD outcome
(HaR: 3.11 (1.12,8.64), p=0.030) in our study population.
We then constructed a bivariate model with each one of the
proposed indices together with the LVEF≤35%. Results are
included in Table IV. We found that only indices I−90V3X and I
90
V2
kept the prognostic value when combined with LVEF.
In these two cases where both the index and the LVEF were
associated to SCD, we identified the group of patients at risk
as those that were simultaneously classified at risk by both
variables. That is, one group of patients at risk was composed
by patients with I−90V3X ≥ thrisk and LVEF≤35% and compared
with the rest of patients at low-risk. In the same way, a second
group at-risk was composed by patients with I90V2 ≥ thrisk
and LVEF≤35%. In both cases, the group of patients at risk
obtained from the combination of both variables presented
more than a 4-fold increased risk in comparison to the rest of
patients (see Table V), improving the hazard ratios obtained
with just the ECG-based indices. When we evaluated the
performance of combined ECG indices (C1 to C8) together
with the LVEF, we got an improved stratification of patients,
remarkably for conditions from C5 to C8, in which probability
of death in patients at risk is more than 6 times higher in
comparison to the rest of patients at the end of the follow-up
period.
TABLE IV
BIVARIATE MODELS FOR SUDDEN CARDIAC DEATH PREDICTION
INCLUDING EACH IV INDEX TOGETHER WITH THE LVEF.
IV index LVEF≤35%
HaR p-value HaR p-value
(95% CI) (95% CI)
I+V3X(+)
2.36 0.070 2.54 0.083
(0.93,5.96) (0.86,7.27)
I+90V3X (+)
2.25 0.095 3.29 0.040
(0.87,5.84) (1.05,10.29)
I−90V3 (+)
2.41 0.067 3.37 0.034
(0.94,6.17) (1.09,10.36)
I−V3X(+)
2.36 0.067 2.62 0.071
(0.94,5.91) (0.92,7.43)
I−90V3X (+)
2.92 0.026 3.13 0.050
(1.13,7.53) (1.00,9.76)
I90V2 (+)
2.55 0.044 2.94 0.039
(1.03,6.36) (1.06,8.18)
LVEF: Left ventricular ejection fraction; HaR: Hazard ratio.
TABLE V
ASSOCIATION OF THE COMBINATION OF THE PROPOSED INDICES AND
LEFT VENTRICULAR EJECTION FRACTION WITH SUDDEN CARDIAC DEATH
IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION.
positive Univariate
patients HaR p-value
(%) (95% CI)
I−90V3X (+)&LVEF≤35%
28 4.86 0.001
(16.4%) (1.91,12.34)
I90V2 (+)&LVEF≤35%
23 4.70 0.001
(13.5%) (1.84,12.00)
C1&LVEF≤35% 26 3.69 0.006
(15.2%) (1.45,9.38)
C2&LVEF≤35% 24 3.47 0.012
(14.0%) (1.32,9.15)
C3&LVEF≤35% 24 4.20 0.003
(14.0%) (1.65,10.67)
C4&LVEF≤35% 24 3.41 0.013
(14.0%) (1.29,9.00)
C5&LVEF≤35% 15 6.91 <0.001
(8.8%) (2.61,18.26)
C6&LVEF≤35% 16 6.99 <0.001
(9.4%) (2.63,18.58)
C7&LVEF≤35% 13 8.71 <0.001
(7.6%) (3.28,23.14)
C8&LVEF≤35% 14 6.47 <0.001
(8.2%) (2.30,18.16)
LVEF: Left ventricular ejection fraction; HaR: Hazard ratio.
V. DISCUSSION
In this study we have proposed new indices able to quantify
ventricular repolarization changes, suitable in the particular
condition of atrial fibrillation, and we have evaluated their
prognostic value in a chronic heart failure population with
AF. We found that both the 3-beat index of ventricular
repolarization variation, I−90V3 , and the 2-beat index of ventric-
ular repolarization variation I90V2 , restricted to heart rates >90
beats/min, which quantify consecutive ventricular repolariza-
tion variations based on a selective beat averaging approach,
were independent predictors of SCD in our study population.
Interestingly, the computation of IV3 in a single-lead basis
2168-2194 (c) 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/JBHI.2018.2851299, IEEE Journal of
Biomedical and Health Informatics
7
led to an improvement in the predictive value when using
lead X (I−V3X, I
−90
V3X , I
+
V3X and I
+90
V3X ). This is not likely due
to a predominant direction of the variations in the direction
of lead X, as X was not the lead where the values of the
parameters were greater. Results suggest either that beat-to-
beat variations in the horizontal left-to-right direction are more
related to arrhythmic risk than variations in other directions
(one possible hypothesis is that this direction is the one better
reflecting apico-basal dispersion, being this the more relevant
for arrhythmia risk), or that a more reliable measurement can
be done in lead X. Further studies could shed light over this.
Moreover, risk stratification based on the combination of
IV3 and I90V2 indices provided with a better identification of
patients at risk of SCD rather than individual indices. Among
clinical and pharmacological variables, only LVEF≤35% was
associated with SCD outcome in our study population. When
combining repolarization variation ECG-indices with this clin-
ical condition for patients’ stratification, hazard ratios were
in all cases greater than LVEF or ECG indices alone. In
particular, probability of death in the group of patients at
risk when IV3 and I90V2 were combined with LVEF was more
than 6 times higher compared to the rest of patients, reaching
an hazard ratio of 8.7 in the best case. It is known that,
although LVEF is not specific in SCD prediction, patients
with low LVEF (≤35%) present higher risk of SCD overall.
Nevertheless, in order to improve ICD effectiveness and reduce
SCD rates in the overall population, it is interesting the study
of the stratification performance of the proposed indices in
patients with preserved LVEF (>35%). Although we found
a better stratification in the LVEF≤35% group, the reduced
number of SCD events in our population, especially in the
preserved LVEF group (only 5 SCD events in patients with
LVEF>35%) limits statistical analysis in this group.
The approach based on selective beat averaging selected
consecutive beats preceded by a similar RR interval (< ±20
ms), from which changes in ventricular repolarization were
assessed using two different strategies. First, selecting triplets
of stable beats, two indices were computed: I+V3, measuring
the average repolarization variation within the triplet, and I−V3,
which could be considered as a measurement of the average
alternant variation in the triplet. The later arises as a first
attempt in the assessment of instantaneous local alternans, as
the irregular ventricular contraction rate during AF prevent
from the evaluation of sustained TWA. However, as the
irregularity in HR increases, it can become challenging to find
3-beats sequences with similar RR along the Holter recording,
and this can compromise the bin characterization. The second
strategy, already proposed in a previous work [18], was an
analysis initially restricted to only two consecutive stable
ventricular repolarizations and, based on that, the 2-beat index
of ventricular repolarization variation, I90V2 , was proposed. This
adds the advantage that more stable pairs than triplets along
the Holter recording resulted available to characterize each bin,
leading to a potentially more robust estimation. In all cases, the
positive association of higher repolarization variability with
SCD outcome in our study population is in agreement with the
fact that repolarization heterogeneity predispose to this fatal
outcome in sinus rhythm patients [11]. Although our indices
are not exactly measuring TWA, we hypothesize that they
may be reflecting intrinsic heterogeneities of repolarization,
dependent on both conduction velocity and inhomogeneity
in action potential duration (APD) of cardiac myocytes. In
the case of CHF hearts, for example, it is known that ion
current remodelling and the prolongation of APD, which
predispose to conduction block and re-entrant arrhythmias,
generate repolarization heterogeneity that may be measured
by the proposed indices [24].
Ventricular repolarization heterogeneity is a rate-dependent
phenomenon, known to be accentuated with increased heart
rates. In TWA analysis, for example, a target heart rate
between 100-120 beats/min is commonly used in the clinical
practice [25]. In this work, a minimum of 90 beats/min has
been considered. That value was obtained in our preliminary
study as a trade-off between the predictability of the index and
the number of patients where the indices were computable.
This parameter was kept unchanged for all the proposed
indices, and we did not intend to optimize its value so as to
avoid the risk of overadaptation, due to the size of the database.
However, we performed a sensitivity analysis, which revealed
that most significative indices preserved also the prognostic
value with hazard ratios ≥1 for minimum heart rates ranging
from 80 up to 110 beats/min, (from 70 beats/min when lead
X was used). Similarly, the value of δ=40 ms represents a
trade-off between the number of pairs/triplets suitable for the
analysis and the required RR stability between consecutive
beats. As stated for the minimum HR, the value of δ was not
either optimized for each index to avoid overmatching our
data. Nevertheless, a sensitivity analysis showed that most
significative indices kept the prognostic value when δ was
set in the range between 40 and 50 ms. Further studies with
bigger-size populations could try to fine-tune the parameters
used for the computation of the indices.
It is also known that ventricular repolarization is very influ-
enced by the heart rate in previous beats, with a memory that
can attain 2-3 min [26, 27]. Therefore, it can be argued that
beats that are averaged within a given bin may present different
repolarization morphologies due to different RR histories.
However, the QT/RR slope, which expresses adaptation of ven-
tricular repolarization to HR, has been shown to be decreased
in AF compared to sinus rhythm [28]. Also, the most important
effect is that of the HR in the previous beat, which is similar in
all averaged beats. In the proposed method, the beats selected
for averaging have stable instantaneous HR and they were
averaged with other beats with similar previous HR. Also, due
to the irregular series of RR intervals that characterizes AF,
it can be expected that the effect of the different long-term
histories will be small. Finally, the averaging is expected to
fade the possible morphological differences, compensating the
different RR histories of the different pairs/triplets.
While the predictive value of several ECG-derived markers,
mainly based on the assessment of ventricular repolarization
heterogeneity has been largely demonstrated in sinus rhythm
[12–16], the high irregularity in the ventricular response that
characterizes AF limits the potential of those indices under
this rhythm. Despite recent data have suggested SCD as the
most common single cause of death in AF patients, rather than
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stroke or deaths from other cardiovascular origin [4, 29], stud-
ies about SCD stratification in patients with AF, in particular
based on electrical instability in the ventricle, are scarce and
the underlying mechanisms that associate AF and SCD are
still intriguing. In some recent studies, it has been suggested
that AF could be intrinsically pro-arrhythmic in the ventricle,
increasing ventricular vulnerability and, consequently, SCD
risk [5–8]. On the other hand, it has also been hypothesized
that AF actually acts by means of other risk factors, as CHF,
increasing SCD incidence [30, 31]. It is evident, therefore
that a more comprehensive understanding of this phenomenon
is still required to improve current treatment strategies. In
this context, non-invasively ascertaining in what patients this
proarrhythmic risk is higher, is crucial for the question of
therapy decision-making.
Several independent predictors associated to SCD in AF
populations have been proposed, including male sex, diabetes,
history of myocardial infarction, heart failure, higher heart
rate and left ventricular hypertrophy, among others [4, 29].
Also a previous study based on the RR series extracted from
high-resolution 20-minute ECG, which included 155 patients
from our study group, showed that a reduced irregularity
in the RR-interval series during AF, measured in terms of
approximate entropy, was able to predict all-cause death and
SCD, in contrast to traditional HRV indices [32]. However,
as far as we know this is the first study in the attempt to
non-invasively stratify CHF patients with AF at risk of SCD
by assessing ventricular repolarization changes from the ECG
signal. These results open the door to further research in the
field. For example, the evaluation of the combination of indices
based on ventricular repolarization dispersion together with the
variability of the ventricular rate (HR-derived indices) may
improve non-invasive stratification performance.
Still, some limitations need to be acknowledged. Although
results obtained in this study have shown prognostic value in
our study population, this population is limited in terms of the
number of SCD events (n=19). Therefore, further prospective
studies in AF populations, with and without CHF, are needed
in order to evaluate the actual clinical value of the indices.
Moreover, this is a post hoc analysis and, as the MUSIC study
was aimed at the evaluation of prognostic models in CHF not
focused on the detailed analysis of AF, relevant information
regarding the clinical course of AF, such as duration, were not
available.
VI. CONCLUSION
In conclusion, increased ventricular repolarization beat-to-
beat variation was associated to SCD in CHF patients with
AF. Both I−90V3 and I
90
V2 , computed from triplets and pairs of
consecutive beats preceded by a similar RR respectively, strat-
ified AF patients according to their risk of SCD, with larger
values associated to lower survival probability. In addition,
risk assessment based on the combination of the proposed
indices led to an improved prognostic value compared to the
individual performance, with a better identification of high-risk
patients. Although results should be confirmed in additional
prospective studies, these results encourage further research
on the evaluation of ventricular repolarization ECG-derived
markers in future studies on patients with AF.
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